DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Cappellini MD.
Iron-chelating therapy with the new oral agent ICL670 (Exjade)
Best Pract Res Clin Haematol 2005; 18: 289-298
We do not assume any responsibility for the contents of the web pages of other providers.